IPOs this week : March 16 - 20, 20 (wk 12)

There are no new pricings on the calendar with the IPO market largely on standby.

IPO lockup expirations

• Envista (NYSE:NVST) and IGM Biosciences (NASDAQ:IGMS) on March 16, as well as 
• Ping Identity (NYSE:PING) and Exagen (NASDAQ:XGN) on March 17.

IPOs this week : Oct 14 - 18, 19 (wk 42)

IPOs expected to price
The only IPO expected to price next week is BellRing Brands (BRBR). The company set an initial range of $16 to $19 for the 30M-share offering.

IPO quiet period expirations
Analyst quiet periods expire on October 14 for

• Datadog (NASDAQ:DDOG),
• Ping Identity (NYSE:PING), 
• Exagen (NASDAQ:XGN), 
• IGM Biosciences (NASDAQ:IGMS) and 
• Envisa (NYSE:NVST). 

IPO lockup expirations
IPO share lockups expire late next week on Pinterest (NYSE:PINS), Zoom Video (NASDAQ:ZM), Brigham Minerals (NYSE:MNRL),Greenlane (NASDAQ:GNLN), Hookipa Pharma (NASDAQ:HOOK) and Genmab (NASDAQ:GMAB).

IPOs this week : Sept 16 - 20, 19 (wk 38)

IPOs expected to price

• Envista (NVST) and IGM Biosciences (IGMS) are expected to price their IPOs on September 17 to be followed by pricings for 
• Datadog (DDOG), Ping Identity Holding (PING) and Exagen (XGN) on September 18. 

IPO lockup expirations

• IPO share lockups arrive on Up Fintech Holding (NASDAQ:TIGR) on September 16, 
• as well as Levi Strauss (NYSE:LEVI) and Canada-traded Cansortium on September 17. 

In other IPO developments to watch, WeWork (WE) will officially begin marketing shares to investors next week ahead with the IPO on track and Anheuser-Busch InBev (NYSE:BUD) will be watched closely for indications of where demand stands for the Budweiser Brewing Co. (BUDBC) IPO.

Also, keep an eye on Peloton (PTON) and its quest for a $1B valuation. D.A. Davidson jumped the gun by rating the exercise equipment company at Neutral even before the IPO has fired off. "While valuation is actually more agreeable than anticipated on forward estimates, it is still fairly robust, and we will wait for a better entry point," stated the firm.